Related Experiment Video
Updated: Jan 31, 2026
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
1.5K
Anthropometric Assessment After Proctocolectomy Due to Ulcerative Colitis.
Hidejiro Kawahara1, Yuki Hiramoto2, Mitsumasa Takeda2
1Department of Surgery, Kashiwa Hospital, Jikei University School of Medicine, Chiba, Japan kawahide@jikei.ac.jp.
In Vivo (Athens, Greece)
|December 28, 2018
Summary
Nutritional status after proctocolectomy for ulcerative colitis (UC) improves by 4 months, with body mass index (BMI) being a key indicator of recovery. This study compared UC patients to rectal cancer patients post-surgery.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Nutritional Science
Background:
- Postoperative nutritional and anthropometric changes after proctocolectomy for ulcerative colitis (UC) require further clarification.
- Understanding these changes is crucial for patient recovery and management.
Purpose of the Study:
- To investigate and compare the postoperative anthropometric and nutritional status of patients undergoing proctocolectomy with temporary ileostomy (PTI) for UC versus low anterior resection (LAR) for rectal cancer.
- To identify key indicators of clinical and nutritional changes following these surgical procedures.
Main Methods:
- A comparative study involving nine UC patients (PTI) and eight rectal cancer patients (LAR) between January 2015 and December 2017.
- Analysis of body weight, BMI, total protein, albumin, cholinesterase, hemoglobin, and lymphocyte counts before surgery and up to 6 months postoperatively.
Main Results:
- UC patients (PTI) exhibited poorer nutritional markers pre-surgery compared to rectal cancer patients (LAR).
- Nutritional markers normalized by 1 month post-surgery in the PTI group.
- Body mass index (BMI) was lower in the PTI group for up to 3 months, with body weight recovery observed from 4 months onwards.
- The LAR group showed no significant postoperative effects on the measured parameters.
Conclusions:
- Body mass index (BMI) is a valuable predictor of postoperative clinical and nutritional status following proctocolectomy for ulcerative colitis.
- Early nutritional deficits in UC patients undergoing proctocolectomy are transient, with recovery indicated by BMI and weight gain.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
32.7K
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
10.6K
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
513
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
513
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
986
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
986
01:28Peptic Ulcer Disease II: Pathophysiology
2.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K
01:30Peptic Ulcer Disease I: Introduction
830
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
830
01:26Peptic Ulcer Disease IV: Management
496
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
496
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.2K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K